Patterns of use and outcomes of adjuvant bevacizumab therapy prior to regulatory approval in women with newly diagnosed ovarian cancer

Gamble, C. R., Chen, L., Szamreta, E., Monberg, M., Hershman, D., & Wright, J. (2022). Patterns of use and outcomes of adjuvant bevacizumab therapy prior to regulatory approval in women with newly diagnosed ovarian cancer. Archives of Gynecology and Obstetrics, 305(6), 1647–1654. https://doi.org/10.1007/s00404-021-06282-6
Authors:
Charlotte R. Gamble
Ling Chen
Elizabeth Szamreta
Matthew Monberg
Dawn Hershman
Jason Wright
Affiliated Authors:
Charlotte R. Gamble
Ling Chen
Dawn Hershman
Jason Wright
Author Keywords:
ovarian neoplasms
bevacizumab
targeted therapeutics
chemotherapy
real-world data
Publication Type:
Article
Unique ID:
10.1007/s00404-021-06282-6
PMID:
Publication Date:
Data Source:
Scopus

Record Created: